Request for Covid-19 Impact Assessment of this Report
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Human Milk Oligosaccharides (HMO) in these regions, from 2012 to 2022 (forecast).
United States Human Milk Oligosaccharides (HMO) market competition by top manufacturers/players, with Human Milk Oligosaccharides (HMO) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott
Inbiose
Company two
Jennewein Biotechnologie
Glycom
ZuChem
Dextra Laboratories
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Neutral HMOs
Acidic HMOs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Milk Oligosaccharides (HMO) for each application, including
Food Industry
Laboratory Research
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Human Milk Oligosaccharides (HMO) Market Report 2017
1 Human Milk Oligosaccharides (HMO) Overview
1.1 Product Overview and Scope of Human Milk Oligosaccharides (HMO)
1.2 Classification of Human Milk Oligosaccharides (HMO) by Product Category
1.2.1 United States Human Milk Oligosaccharides (HMO) Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Human Milk Oligosaccharides (HMO) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Neutral HMOs
1.2.4 Acidic HMOs
1.3 United States Human Milk Oligosaccharides (HMO) Market by Application/End Users
1.3.1 United States Human Milk Oligosaccharides (HMO) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Food Industry
1.3.3 Laboratory Research
1.4 United States Human Milk Oligosaccharides (HMO) Market by Region
1.4.1 United States Human Milk Oligosaccharides (HMO) Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)
1.4.3 Southwest Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)
1.4.5 New England Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)
1.4.6 The South Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)
1.4.7 The Midwest Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Milk Oligosaccharides (HMO) (2012-2022)
1.5.1 United States Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2022)
1.5.2 United States Human Milk Oligosaccharides (HMO) Revenue and Growth Rate (2012-2022)
2 United States Human Milk Oligosaccharides (HMO) Market Competition by Players/Suppliers
2.1 United States Human Milk Oligosaccharides (HMO) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Milk Oligosaccharides (HMO) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Milk Oligosaccharides (HMO) Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Milk Oligosaccharides (HMO) Market Competitive Situation and Trends
2.4.1 United States Human Milk Oligosaccharides (HMO) Market Concentration Rate
2.4.2 United States Human Milk Oligosaccharides (HMO) Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution, Sales Area, Product Type
3 United States Human Milk Oligosaccharides (HMO) Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Human Milk Oligosaccharides (HMO) Sales and Market Share by Region (2012-2017)
3.2 United States Human Milk Oligosaccharides (HMO) Revenue and Market Share by Region (2012-2017)
3.3 United States Human Milk Oligosaccharides (HMO) Price by Region (2012-2017)
4 United States Human Milk Oligosaccharides (HMO) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Human Milk Oligosaccharides (HMO) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Milk Oligosaccharides (HMO) Revenue and Market Share by Type (2012-2017)
4.3 United States Human Milk Oligosaccharides (HMO) Price by Type (2012-2017)
4.4 United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Type (2012-2017)
5 United States Human Milk Oligosaccharides (HMO) Sales (Volume) by Application (2012-2017)
5.1 United States Human Milk Oligosaccharides (HMO) Sales and Market Share by Application (2012-2017)
5.2 United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Human Milk Oligosaccharides (HMO) Players/Suppliers Profiles and Sales Data
6.1 Abbott
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Inbiose
6.2.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Company two
6.3.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Company two Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Jennewein Biotechnologie
6.4.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Glycom
6.5.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 ZuChem
6.6.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Dextra Laboratories
6.7.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
...
7 Human Milk Oligosaccharides (HMO) Manufacturing Cost Analysis
7.1 Human Milk Oligosaccharides (HMO) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Human Milk Oligosaccharides (HMO) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Milk Oligosaccharides (HMO) Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Human Milk Oligosaccharides (HMO) Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Human Milk Oligosaccharides (HMO) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Milk Oligosaccharides (HMO) Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Milk Oligosaccharides (HMO) Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Milk Oligosaccharides (HMO) Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of Human Milk Oligosaccharides (HMO)
Figure United States Human Milk Oligosaccharides (HMO) Market Size (MT) by Type (2012-2022)
Figure United States Human Milk Oligosaccharides (HMO) Sales Volume Market Share by Type (Product Category) in 2016
Figure Neutral HMOs Product Picture
Figure Acidic HMOs Product Picture
Figure United States Human Milk Oligosaccharides (HMO) Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Human Milk Oligosaccharides (HMO) by Application in 2016
Figure Food Industry Examples
Table Key Downstream Customer in Food Industry
Figure Laboratory Research Examples
Table Key Downstream Customer in Laboratory Research
Figure United States Human Milk Oligosaccharides (HMO) Market Size (Million USD) by Region (2012-2022)
Figure The West Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Milk Oligosaccharides (HMO) Sales (MT) and Growth Rate (2012-2022)
Figure United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Milk Oligosaccharides (HMO) Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Milk Oligosaccharides (HMO) Sales Share by Players/Suppliers
Figure 2017 United States Human Milk Oligosaccharides (HMO) Sales Share by Players/Suppliers
Figure United States Human Milk Oligosaccharides (HMO) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Milk Oligosaccharides (HMO) Revenue Share by Players/Suppliers
Figure 2017 United States Human Milk Oligosaccharides (HMO) Revenue Share by Players/Suppliers
Table United States Market Human Milk Oligosaccharides (HMO) Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Milk Oligosaccharides (HMO) Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Human Milk Oligosaccharides (HMO) Market Share of Top 3 Players/Suppliers
Figure United States Human Milk Oligosaccharides (HMO) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Milk Oligosaccharides (HMO) Product Category
Table United States Human Milk Oligosaccharides (HMO) Sales (MT) by Region (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Sales Share by Region (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Sales Share by Region (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Sales Market Share by Region in 2016
Table United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Revenue Share by Region (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Revenue Market Share by Region in 2016
Table United States Human Milk Oligosaccharides (HMO) Price (USD/Kg) by Region (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Sales (MT) by Type (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Sales Share by Type (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Sales Share by Type (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Sales Market Share by Type in 2016
Table United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Milk Oligosaccharides (HMO) by Type (2012-2017)
Figure Revenue Market Share of Human Milk Oligosaccharides (HMO) by Type in 2016
Table United States Human Milk Oligosaccharides (HMO) Price (USD/Kg) by Types (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Type (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Sales (MT) by Application (2012-2017)
Table United States Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Sales Market Share by Application in 2016
Table United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Application (2012-2017)
Figure United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Application (2012-2017)
Table Abbott Basic Information List
Table Abbott Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abbott Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)
Figure Abbott Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)
Figure Abbott Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)
Table Inbiose Basic Information List
Table Inbiose Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Inbiose Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)
Figure Inbiose Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)
Figure Inbiose Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)
Table Company two Basic Information List
Table Company two Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Company two Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)
Figure Company two Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)
Figure Company two Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)
Table Jennewein Biotechnologie Basic Information List
Table Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)
Figure Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)
Figure Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)
Table Glycom Basic Information List
Table Glycom Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Glycom Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)
Figure Glycom Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)
Figure Glycom Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)
Table ZuChem Basic Information List
Table ZuChem Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ZuChem Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)
Figure ZuChem Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)
Figure ZuChem Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)
Table Dextra Laboratories Basic Information List
Table Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)
Figure Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)
Figure Dextra Laboratories Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Milk Oligosaccharides (HMO)
Figure Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)
Figure Human Milk Oligosaccharides (HMO) Industrial Chain Analysis
Table Raw Materials Sources of Human Milk Oligosaccharides (HMO) Major Players/Suppliers in 2016
Table Major Buyers of Human Milk Oligosaccharides (HMO)
Table Distributors/Traders List
Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Milk Oligosaccharides (HMO) Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Type in 2022
Table United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Application in 2022
Table United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Human Milk Oligosaccharides (HMO) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Milk Oligosaccharides (HMO) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Milk Oligosaccharides (HMO) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...